On Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q4 2023 earnings per share (EPS) of -$1.99, up 68.31% year over year. Total Arcadia Biosciences earnings for the quarter were -$2.85 million. In the same quarter last year, Arcadia Biosciences's earnings per share (EPS) was -$6.28.
As of Q2 2024, Arcadia Biosciences's earnings has grown year over year. Arcadia Biosciences's earnings in the past year totalled -$13.98 million.
What is RKDA's earnings date?
Arcadia Biosciences's earnings date is Invalid Date. Add RKDA to your watchlist to be reminded of RKDA's next earnings announcement.
What was RKDA's revenue last quarter?
On Invalid Date, Arcadia Biosciences (NASDAQ: RKDA) reported Q4 2023 revenue of $1.17 million up 57.26% year over year. In the same quarter last year, Arcadia Biosciences's revenue was $744.00 thousand.
What was RKDA's revenue growth in the past year?
As of Q2 2024, Arcadia Biosciences's revenue has grown -28.15% year over year. This is 32.81 percentage points lower than the US Packaged Foods industry revenue growth rate of 4.66%. Arcadia Biosciences's revenue in the past year totalled $5.33 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.